#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13902	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2166	637.5	0	.	n	.	0	C451T	SNP	451	451	C	728	728	T	781	T,C	416,314	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13902	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2166	637.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1461	1461	C	799	C	745	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24898	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3672	676.2	0	.	n	.	0	T695C	SNP	695	695	T	1055	1055	C	775	C	736	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24898	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3672	676.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2331	2331	C	752	C,T	700,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24898	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3672	676.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2405	2405	A	774	A	742	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24898	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3672	676.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2957	2957	C	822	C,A	777,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2004	folP	855	855	100.0	folP.l15.c4.ctg.1	1523	130.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1070	1072	AGC	200;201;202	A;G;C	189;189;189	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5308	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3487	151.9	1	SNP	p	S91F	1	.	.	271	273	TTC	609	611	TTC	200;201;201	T;T;C	185;185;185	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5308	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3487	151.9	1	SNP	p	D95G	1	.	.	283	285	GGC	621	623	GGC	191;188;189	G;G;C	178;174;172	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5308	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3487	151.9	1	SNP	p	G95N	0	.	.	283	285	GGC	621	623	GGC	191;188;189	G;G;C	178;174;172	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1566	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1363	114.4	1	SNP	p	G45D	0	.	.	133	135	GGC	540	542	GGC	177;178;177	G;G;C	164;163;162	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	890	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	949	93.1	0	.	n	.	0	A197.	DEL	197	197	A	551	551	A	210	A	196	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4956	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2925	168.5	1	SNP	p	D86N	0	.	.	256	258	GAC	548	550	GAC	169;166;165	G;A;C	163;157;160	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4956	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2925	168.5	1	SNP	p	R87I	0	.	.	259	261	CGT	551	553	CGT	164;166;165	C;G;T	158;157;152	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4956	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2925	168.5	1	SNP	p	S87R	1	.	.	259	261	CGT	551	553	CGT	164;166;165	C;G;T	158;157;152	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4956	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2925	168.5	1	SNP	p	R87W	0	.	.	259	261	CGT	551	553	CGT	164;166;165	C;G;T	158;157;152	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4956	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2925	168.5	1	SNP	p	S88P	0	.	.	262	264	TCC	554	556	TCC	164;162;162	T;C;C	157;155;154	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3984	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2469	159.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1450	1452	GGC	203;204;201	G;G;C	193;195;188	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	539	3508	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2469	141.5	0	.	p	.	0	G499S	NONSYN	1495	1497	GGT	1826	1828	AGT	203;202;204	A,G;G;T	188,1;188;191	.	.
penA.34.001	penA.34.001	1	1	539	3508	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2469	141.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1262	1264	GCC	157;157;163	G;C,T;C	152;150,1;159	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	3508	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2469	141.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1265	1267	ATG	162;162;162	A;T;G	158;159;159	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	3508	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2469	141.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1277	1279	ACC	166;168;171	A;C;C	158;165;166	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	3508	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2469	141.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1277	1279	ACC	166;168;171	A;C;C	158;165;166	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	3508	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2469	141.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1778	1780	ACC	195;194;196	A;C;C	175;178;180	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	3508	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2469	141.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1832	1834	GCG	200;200;199	G,C;C;G	186,1;184;185	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	3508	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2469	141.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1832	1834	GCG	200;200;199	G,C;C;G	186,1;184;185	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	3508	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2469	141.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1955	1957	GGT	171;171;168	G;G;T	160;162;155	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	3508	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2469	141.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1964	1966	AGC	157;157;157	A;G;C	149;147;143	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	539	3508	penA	1746	1746	99.94	penA.l15.c4.ctg.1	2469	141.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1982	1984	CCG	132;131;128	C,G;C;GCCC,GGCCCC	99,4;97;92,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5348	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3024	175.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1569	1571	CCG	209;209;207	C;C;G,A	182;195;176,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2448	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1912	127.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	610	610	C	181	C	169	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2578	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1581	162.2	0	.	p	.	0	G129S	NONSYN	385	387	GGC	669	671	AGC	196;195;197	A,G;G;C	183,1;185;182	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2578	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1581	162.2	0	.	p	.	0	G256D	NONSYN	766	768	GGT	1050	1052	GAT	208;202;204	G;A,G;T	198;193,1;192	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2578	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1581	162.2	1	SNP	p	G120K	1	.	.	358	360	AAG	642	644	AAG	209;207;205	A,G;A,G;G,C	194,1;196,1;187,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2578	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1581	162.2	1	SNP	p	A121N	1	.	.	361	363	AAC	645	647	AAC	204;203;205	A;A,G;C	191;194,1;192	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2578	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1581	162.2	1	SNP	p	N121D	0	.	.	361	363	AAC	645	647	AAC	204;203;205	A;A,G;C	191;194,1;192	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9814	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4860	201.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1018	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	989	101.9	1	SNP	p	V57M	1	.	.	169	171	ATG	480	482	ATG	191;193;193	A;T;G	188;190;190	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
